Home Health Business Quarterly: Blood thinning agent approved
Home Health Business Quarterly
Blood thinning agent approved
For the first time, the U.S. Food & Drug Administration has approved a blood-thinning agent for the prevention of blood clots know as deep-vein thrombosis.
Lovenox, a low-molecular weight heparin from Aventis Pharmaceuticals in Parsippany, NJ, was approved for patients with restricted mobility at risk for thromboembolic complications from illnesses such as heart failure, respiratory failure, severe infection, back pain, vertebral compression, and arthritic episodes.
Subscribe Now for Access
You have reached your article limit for the month. We hope you found our articles both enjoyable and insightful. For information on new subscriptions, product trials, alternative billing arrangements or group and site discounts please call 800-688-2421. We look forward to having you as a long-term member of the Relias Media community.